2. Raffles Medical Group
Raffles Medical Group is a leading integrated private healthcare provider in Asia, operating medical facilities in 14 cities in Singapore, China. Japan, Vietnam and Cambodia.
It is the only private medical provider in Singapore that owns and operates a fully integrated healthcare organisation comprising a tertiary hospital, a network of family and dental clinics, traditional Chinese Medicine and a consumer healthcare division.
Raffles medical Group's revenue increase by 5.9% to $766.5M while net profit increase by 71.7% to $143.7M for the year ended 31 Dec 2022. The company declared a dividend of 3.8 cents in 2022 which is an increase from 2.8 cents in 2021.
With the reopening of borders and easing of COVID-19 related protocols, the Group saw a return of foreign patients seeking medical treatment in Singapore.
The Group started Singapore’s first Transitional Care Facility in July 2022 for managing chronically ill patients from public hospitals to alleviate the burden on the public healthcare system.
This will augur well for the company future growth due to the government emphasis on alleviating the burden of public hospitals.
Another area of growth is the launch of Healthier SG in partnership with the Ministry of Health. Raffles Medical is an active participant of the Ministry of Health’s recently launched Healthier SG initiative.
Patients who enrol with any Raffles Medical clinic can enjoy a more seamless experience with both the Group’s in-house clinic management system and e-Medical Records system now fully integrated with the National Electronic Health Record.
You can view Raffles Medical Group FY 2022 results
here.
3. BRC Asia
BRC Asia is the leading steel reinforcement solutions provider in Singapore. The company had a hand in reinforcing projects in commercial and cultural landmarks such as the National Library of Singapore, Marina Bay Financial Centre, Marina Bay Sands, Pinnacle @ Duxton, and Gardens by the Bay.
For the year ended 30 September 2022, revenue increase by 45% to $1.7 billion while net profit increase by 92% to $90.2 million. This was a result of both increased sales volume and higher steel prices.
The Group declared a final dividend of 6 Singapore cents and a special dividend of 6 Singapore cents. Together with the interim dividend of 6 Singapore cents, the total dividend declared for FY2022 is 18 cents. This is higher than FY2021 dividend of 12 cents.
The Ministry of Trade and Industry forecast a growth in the construction sector of 3.3% y-o-y. This growth is attributed to the expansion in both the private and public sector's construction projects.
As of 30 June 2023, the company sales order book stood at approximately S$1.34 billion. The duration of projects in the order book range up to 5 years. This bodes well for the company going forward.
You can view BRC Asia FY 2022 results
here.